Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-seq of liver tissue and liver cancer cell lines

ABSTRACT: RNA-seq of liver tissue and liver cancer cell lines

PROVIDER: PRJEB11781 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR1138630_1.fastq.gz	Fastqsanger.gz
	ERR1138630_2.fastq.gz	Fastqsanger.gz
	ERR1138640_1.fastq.gz	Fastqsanger.gz
	ERR1138640_2.fastq.gz	Fastqsanger.gz
	ERR1138631_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 30

Similar Datasets

Sequencing of liver cancer cell lines

Project description:Liver cancer is a dreadful disease with limited therapeutic options. How to translate genomic findings into biomarkers and precision treatment is challenging. A large cell line-based platform was established, termed as Liver Cancer Model Repository. Heterogeneities in patients were faithfully recapitulated by 81 liver cancer cell lines at genomic and transcriptomic levels. This platform provides a rich resource and models to study cancer drivers and drug responses in liver cancer.

| EGAS00001002237 | EGA

RNAseq data of 81 liver cancer cell lines

Project description:A large panel of 81 liver cancer cell models, designated as LIver cancer MOdel REpository (LIMORE) was constructed. These cell lines include 31 public cell lines and 50 new cell models establishend from Chinese liver cancer patients. Whole genome sequencing (WGS), exome sequencing (WES) and RNA sequencing (RNAseq) were performed to obtain the genetic information for these cell lines. These cell lines and associated data provide new models and also a rich resource for liver cancer.

2019-06-17 | GSE97098 | GEO

Pol III ChIP-seq of liver cancer cell lines

Project description:Pol III ChIP-seq of liver cancer cell lines

| PRJEB11765 | ENA

Small RNA-seq analysis of human liver cancer cell lines and human liver tissues

Project description:Small RNA-seq analysis of human liver cancer cell lines and human liver tissues

| PRJNA526636 | ENA

RNA-seq of human liver cancer cell lines after RBP-KD

Project description:RNA-seq of human liver cancer cell lines after RBP-KD

| PRJEB40455 | ENA

Small RNA-seq analysis of human liver cancer cell lines and human liver tissues

Project description:We applied small RNA sequencing technology to identify precursor tRNA derived small RNA expression in human cancer cell lines and human liver tissues.

2022-03-09 | GSE128164 | GEO

Tissue-specific transcription reprogramming promotes liver metastasis of colorectal cancer (RNA-Seq)

Project description:Metastasis is the cause of death for 90% of cancer patients, but little is known about how cancer cells adapt to and colonize new tissue environments. Using clinical samples and primary/metastatic cell lines, we found metastatic colorectal cancer (CRC) cells lose their colon-specific gene transcription program and gain a liver-specific gene transcription program as they metastasize in the liver. We revealed this transcription reprogramming is driven by a reshaped epigenetic landscape of both typical and super-enhancers. Further, we identified FOXA2, a liver-specific transcription factor, plays a key role in this transcription reprogramming and the colonization of metastatic CRC cells in the liver. Notably, this transcription reprogramming is also observed in multiple cancer types. Our data demonstrate that epigenetically reprogrammed tissue-specific transcription promotes metastasis and should be targeted therapeutically.

2020-06-30 | GSE106920 | GEO

RNA-seq of coding RNA from samples of 20 human individuals representing four cancers: glioma, colon cancer, liver cancer and testicular cancer, as well as three cell lines.

Project description:RNA-seq was performed of cancer samples from 20 human individuals representing four cancers: glioma, colon cancer, liver cancer and testicular cancer, as well as six samples from the three cell lines NTERA-2, U-87 MG och U-138 MG in order to study the human tissue transcriptome.

2024-02-26 | E-MTAB-4681 | biostudies-arrayexpress

Effect of zebularine on primary human liver cancer cell lines

Project description:Transcriptomic changes in human liver cancer cell lines caused by the demethylating drug zebularine. Epigenomic changes such as aberrant hypermethylation and subsequent atypical gene silencing are characteristic features of human cancer. Here, we report a comprehensive characterization of epigenomic modulation caused by zebularine, an effective DNA methylation inhibitor, in human liver cancer. Using transcriptomic and epigenomic profiling, we identified a zebularine signature that classified liver cancer cell lines into two major subtypes with different drug-responses. In drug-sensitive cell lines, zebularine caused inhibition of proliferation coupled with increased apoptosis, whereas drug-resistant cell lines were associated with upregulation of oncogenic networks (e.g. E2F1, MYC, and TNF) driving liver cancer growth in vitro and in mice. Assessment of zebularine-based therapy in xenograft mouse models demonstrated potent therapeutic effects against tumors established from zebularine-sensitive but not zebularine-resistant liver cancer cells leading to increased survival and decreased pulmonary metastasis. Integration of zebularine gene expression and demethylation response signatures differentiated patients with HCC according to their survival and disease recurrence and identified a subclass of patients within the poor survivors likely to benefit from therapeutic agents that target the cancer epigenome.

2011-07-31 | GSE23991 | GEO

RNA sequencing of mouse liver cancer cell lines with YAP/TAZ mutations

Project description:RNA sequencing of mouse liver cancer cell lines with YAP/TAZ mutations

| PRJNA483883 | ENA